US › Healthcare

Guardian Pharmacy Services, Inc. (GRDN)

US · Healthcare · Medical Care Facilities

$40.53-0.69%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$336.6M

Revenue YoY

+2.2%

Net profit

$13.3M

Profit YoY

+40.7%

EPS

$0.29

EPS estimate

$0.24

Net margin

3.9%

EPS came in at 0.29 against a street estimate of 0.24 — a beat of 20.8%.

Key statistics

Market cap

$2.58B

P/E

48.6

Forward P/E

32.2

P/B

11.33

Book value

$3.49

EPS (TTM)

$0.84

52-week high

$44.00

52-week low

$19.30

50-day MA

$40.54

200-day MA

$34.42

Analyst view

Analysts rate Guardian Pharmacy Services, Inc. a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $47.00.

Shareholding

Insiders

37.52%

Institutions

59.71%

Largest institutional holders

Fund	Stake
FMR Inc	3.73%
Wellington Management Company LLP	2.79%
BlackRock Inc	2.77%
Woodline Partners LP	2.06%
Brown Advisory Holdings Inc	1.99%
Vanguard Capital Management, LLC	1.94%
Valiant Capital Management LP	1.87%
TimesSquare Capital Management, LLC	1.70%

Recent filings & reports

Document	Date
Board / officer change · Q2 2026	2026-06-22
Material agreement · Q2 2026	2026-05-28
Shareholder vote results · Q2 2026	2026-05-07
Quarterly report · Q1 2026	2026-05-06
Results announced · Q2 2026	2026-05-06
Proxy statement · Q2 2026	2026-03-26
Annual report FY2025	2026-03-11
Quarterly report · Q3 2025	2025-11-10

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Guardian Pharmacy Services, Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.